Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net loss	$ (16,729,642)	$ (18,374,354)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	73,727	51,956
Stock-based compensation expense	389,299	813,499
Changes in assets and liabilities:
Accounts receivable	(547,574)	0
Prepaid expenses and other current assets	312,840	707,084
Other assets	(1,116,778)	(986,498)
Accounts payable and accrued expenses	(911,709)	2,333,791
Total adjustments	(192,319)	3,478,660
Net cash used in operating activities	(16,921,961)	(14,895,694)
Cash flows from investing activities:
Purchase of equipment	(20,653)	(29,997)
Net cash used in investing activities	(20,653)	(29,997)
Cash flows from financing activities:
Net proceeds from issuance of notes payable – related parties	135,000	0
Repayment of notes payable – related parties	(150,000)	0
Net proceeds from sale of common stock and warrants	16,730,415	0
Net proceeds from warrant exercise	2,367,133	0
Net cash provided by financing activities	19,082,548	0
Net increase (decrease) in cash and cash equivalents	2,139,934	(14,925,691)
Cash and cash equivalents at beginning of period	6,452,589	27,612,732
Cash and cash equivalents at end of period	$ 8,592,523	$ 12,687,041